Neogen Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
12.9%projected annual EPS growth
Analyst Coverage
3analysts covering
FY Revenue (est.)
$883.2Mnext fiscal year
FY EPS (est.)
$0.31next fiscal year
Monitoring Framework
Key Performance Indicators
Food Safety Segment Core Revenue Growth Quarterly400.0%
Animal Safety Segment Core Revenue Growth Quarterly-870.0%
Adjusted EBITDA Margin Quarterly2,280.0%
Watch Items
- Petrifilm Manufacturing TransitionTrigger: Completion target of November 2026Action: Monitor SKU validation and the elimination of duplicative manufacturing costs during the Petrifilm manufacturing transition.
- Animal Safety Supplier DisruptionsAction: Manage Animal Safety supply chain challenges and third-party supplier transitions.
- Genomics Business Divestiture to ZoetisTrigger: Expected to close in Q2 fiscal 2027Action: Track regulatory approvals and closing adjustments to secure estimated net proceeds of $140 million for debt reduction.
Research as of 20 Jun 2026